Assessment of circulating insulin using liquid chromatography-mass spectrometry during insulin glargine treatment in type 2 diabetes: Implications for estimating insulin sensitivity and β-cell function

被引:3
作者
Seegmiller, Jesse J. [1 ,5 ]
Schmit, David L. [1 ]
Arends, Valerie W. [1 ]
Steffes, Michael E. [1 ]
Kahn, Steven [2 ,3 ]
Younes, Naji [4 ]
GRADE Res Grp
机构
[1] Univ Minnesota, Dept Lab Med, Adv Res & Diagnost Lab, Minneapolis, MN USA
[2] VA Puget Sound Hlth Care Syst, Div Metab Endocrinol & Nutr, Seattle, WA USA
[3] Univ Washington, Seattle, WA USA
[4] George Washington Univ, Milken Inst Sch Publ Hlth, Biostat Ctr, Dept Biostat & Bioinformat, Rockville, MD USA
[5] Univ Minnesota, Dept Lab Med, Adv Res & Diagnost Lab, Minneapolis, MN 55415 USA
关键词
HOMA; immunoassay; insulin analogues; insulin sensitivity; oral glucose tolerance test; type; 2; diabetes; beta-cell function; ORAL GLUCOSE-TOLERANCE; CROSS-REACTIVITY; SECRETION; ANALOGS; STANDARDIZATION; IMMUNOASSAYS; PLASMA; PHARMACOKINETICS; PHARMACODYNAMICS; INHIBITION;
D O I
10.1111/dom.15072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To determine the potential impact of the cross-reactivity of insulin glargine U-100 and its metabolites on insulin sensitivity and beta-cell measures in people with type 2 diabetes. Materials and Methods: Using liquid chromatography-mass spectrometry (LC-MS), we measured concentrations of endogenous insulin, glargine and its two metabolites (M1 and M2) in fasting and oral glucose tolerance test-stimulated plasma from 19 participants and fasting specimens from another 97 participants 12 months after randomization to receive the insulin glargine. The last dose of glargine was administered before 10:00 PM the night before testing. Insulin was also measured on these specimens using an immunoassay. We used fasting specimens to calculate insulin sensitivity (Homeostatic Model Assessment 2 [HOMA2]-S%; QUICKI index; PREDIM index) and beta-cell function (HOMA2-B%). Using specimens following glucose ingestion, we calculated insulin sensitivity (Matsuda ISI[comp] index) and beta-cell response (insulinogenic index [IGI], and total incremental insulin response [iAUC] insulin/glucose). Results: In plasma, glargine was metabolized to form the M1 and M2 metabolites that were quantifiable by LC-MS; however, the analogue and its metabolites cross-reacted by less than 100% in the insulin immunoassay. This incomplete cross-reactivity resulted in a systematic bias of fasting-based measures. By contrast, because M1 and M2 did not change following glucose ingestion, a bias was not observed for IGI and iAUC insulin/glucose. Conclusions: Despite glargine metabolites being detected in the insulin immunoassay, dynamic insulin responses can be used to assess beta-cell responsiveness. However, given the cross-reactivity of the glargine metabolites in the insulin immunoassay, fasting-based measures of insulin sensitivity and beta-cell function are biased.
引用
收藏
页码:1995 / 2004
页数:10
相关论文
共 38 条
  • [1] Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis
    Bismuth, Elise
    Laborde, Kathleen
    Talipin, Pierre
    Velho, Gilberto
    Ribault, Virginie
    Jennane, Farida
    Grasset, Etienne
    Sermet, Isabelle
    De Blic, Jacques
    Lenoir, Gerard
    Robert, Jean-Jacques
    [J]. JOURNAL OF PEDIATRICS, 2008, 152 (04) : 540 - 545
  • [2] Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes
    Bolli, Geremia B.
    Hahn, Annke D.
    Schmidt, Ronald
    Eisenblaetter, Tanja
    Dahmen, Raphael
    Heise, Tim
    Becker, Reinhard H. A.
    [J]. DIABETES CARE, 2012, 35 (12) : 2626 - 2630
  • [3] Multidimensional LC-MS/MS Enables Simultaneous Quantification of Intact Human Insulin and Five Recombinant Analogs in Human Plasma
    Chambers, Erin E.
    Fountain, Kenneth J.
    Smith, Norman
    Ashraf, Leah
    Karalliedde, Janaka
    Cowan, David
    Legido-Quigley, Cristina
    [J]. ANALYTICAL CHEMISTRY, 2014, 86 (01) : 694 - 702
  • [4] Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different
    Cheng, Alice Y. Y.
    Patel, Dhiren K.
    Reid, Timothy S.
    Wyne, Kathleen
    [J]. ADVANCES IN THERAPY, 2019, 36 (05) : 1018 - 1030
  • [5] FEEDBACK INHIBITION OF INSULIN-SECRETION BY INSULIN - RELATION TO THE HYPERINSULINEMIA OF OBESITY
    ELAHI, D
    NAGULESPARAN, M
    HERSHCOPF, RJ
    MULLER, DC
    TOBIN, JD
    BLIX, PM
    RUBENSTEIN, AH
    UNGER, RH
    ANDRES, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (20) : 1196 - 1202
  • [6] Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
    Fraticelli, Federica
    Celentano, Claudio
    Zecca, Isaia A. L.
    Di Vieste, Giacoma
    Pintaudi, Basilio
    Liberati, Marco
    Franzago, Marica
    Di Nicola, Marta
    Vitacolonna, Ester
    [J]. ACTA DIABETOLOGICA, 2018, 55 (08) : 805 - 812
  • [7] Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study
    Gomez-Martinez, Carlos
    Babio, Nancy
    Julvez, Jordi
    Becerra-Tomas, Nerea
    Martinez-Gonzalez, Miguel A.
    Corella, Dolores
    Castaner, Olga
    Romaguera, Dora
    Vioque, Jesus
    Alonso-Gomez, Angel M.
    Warnberg, Julia
    Martinez, Jose A.
    Serra-Majem, Luis
    Estruch, Ramon
    Tinahones, Francisco J.
    Lapetra, Jose
    Pinto, Xavier
    Tur, Josep A.
    Lopez-Miranda, Jose
    Bueno-Cavanillas, Aurora
    Gaforio, Jose J.
    Matia-Martin, Pilar
    Daimiel, Lidia
    Martin-Sanchez, Vicente
    Vidal, Josep
    Vazquez, Clotilde
    Ros, Emilio
    Dalsgaard, Soren
    Sayon-Orea, Carmen
    Sorli, Jose, V
    de la Torre, Rafael
    Abete, Itziar
    Tojal-Sierra, Lucas
    Baron-Lopez, Francisco J.
    Fernandez-Brufal, Noelia
    Konieczna, Jadwiga
    Garcia-Rios, Antonio
    Sacanella, Emilio
    Bernal-Lopez, M. Rosa
    Santos-Lozano, Jose M.
    Razquin, Cristina
    Alvarez-Sala, Andrea
    Goday, Albert
    Angeles Zulet, M.
    Vaquero-Luna, Jessica
    Diez-Espino, Javier
    Cuenca-Royo, Aida
    Fernandez-Aranda, Fernando
    Bullo, Monica
    Salas-Salvado, Jordi
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [8] Most commercial insulin assays fail to detect recombinant insulin analogues
    Heald, A. H.
    Bhattacharya, B.
    Cooper, H.
    Ullah, A.
    McCulloch, A.
    Smellie, S.
    Wark, G.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2006, 43 : 306 - 308
  • [9] Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification
    Heurtault, Beatrice
    Reix, Nathalie
    Meyer, Nicolas
    Gasser, Francoise
    Wendling, Marie-Josee
    Ratomponirina, Charline
    Jeandidier, Nathalie
    Sapin, Remy
    Agin, Arnaud
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (03) : 355 - 362
  • [10] The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences
    Home, P. D.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (09) : 780 - 788